iothalamic acid has been researched along with Glycogen Storage Disease Type I in 1 studies
Iothalamic Acid: A contrast medium in diagnostic radiology with properties similar to those of diatrizoic acid. It is used primarily as its sodium and meglumine (IOTHALAMATE MEGLUMINE) salts.
Glycogen Storage Disease Type I: An autosomal recessive disease in which gene expression of glucose-6-phosphatase is absent, resulting in hypoglycemia due to lack of glucose production. Accumulation of glycogen in liver and kidney leads to organomegaly, particularly massive hepatomegaly. Increased concentrations of lactic acid and hyperlipidemia appear in the plasma. Clinical gout often appears in early childhood.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Martens, DH | 1 |
| Rake, JP | 1 |
| Navis, G | 1 |
| Fidler, V | 1 |
| van Dael, CM | 1 |
| Smit, GP | 1 |
1 other study available for iothalamic acid and Glycogen Storage Disease Type I
| Article | Year |
|---|---|
Renal function in glycogen storage disease type I, natural course, and renopreservative effects of ACE inhibition.
Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Child; Child, Preschool; Contrast Media; Dise | 2009 |